Thyroid hormone therapy modulates hypothalamo-pituitary-adrenal axis

Area of Science:

• Endocrinology
• Neuroendocrinology
• Hormone therapy research

Background:

• The hypothalamo-pituitary-adrenal (HPA) axis regulates stress response.
• Thyroid hormones significantly impact HPA axis function.
• Understanding these interactions is crucial for managing endocrine disorders.

Purpose of the Study:

• To investigate the effect of thyroid hormone therapy on HPA axis activity.
• To assess adrenocorticotropin (ACTH) and cortisol responses to human corticotropin-releasing hormone (hCRH) in athyreotic women.
• To compare HPA axis function in hypothyroid and subclinically hyperthyroid states.

Main Methods:

• Studied 14 athyreotic women undergoing thyroid suppression therapy with thyroxine (T4).
• Measured plasma ACTH and cortisol levels before and after T4 therapy.
• Administered hCRH intravenously and assessed hormonal responses.
• Included a control group of seven healthy women for comparison.

Main Results:

• The patient group showed a greater increase in ACTH following hCRH stimulation compared to controls, both before and after T4 therapy.
• Plasma cortisol levels also exhibited a more pronounced increase in patients post-hCRH stimulation than in controls.
• These findings indicate altered HPA axis responsiveness in patients with thyroid dysfunction or hormone therapy.

Conclusions:

• Both hypothyroidism and subclinical hyperthyroidism induced by suppressive thyroid hormone doses result in ACTH hypersensitivity to hCRH.
• The underlying mechanisms for this hypersensitivity may differ between hypothyroid and subclinically hyperthyroid states.
• Thyroid hormone status plays a critical role in modulating the HPA axis response to stimulation.